Shilpa Medicare

Premium

Healthcare

20 February, 2024

TA Associates scores a dud from India portfolio exit

Private equity firm TA Associates, which struck a clutch of exits last year harvesting over $500 million from India and ......

Premium

Healthcare

07 November, 2022

Shilpa Medicare plans API biz stake sale

Shilpa Medicare plans to sell a stake in its API (Active Pharmaceutical Ingredient) business, its high-revenue generating unit that was ......

Finance

24 May, 2022

Bears take charge after early gains for second straight session

Markets gave up early gains to trade lower on Tuesday, weighed down by IT and consumer stocks, while logistics firm ......

Healthcare

09 October, 2018

Chronic therapies to drive PE investments in pharma: IQVIA report

Chronic therapies and oncology in particular will be among the key drivers of private equity investments in the Indian pharmaceuticals ......

Premium

Finance

15 March, 2018

Tano Capital poised to strike gold with second private equity fund

Asia-focussed alternative asset management firm Tano Capital LLC has executed a series of partial exits in recent months, helping it ......

Premium

Healthcare

24 July, 2017

TA Associates scoring above-average return from another India portfolio firm

US-based private equity investor TA Associates has offloaded over two-thirds of its stake in an India portfolio firm en route ......

TMT

02 January, 2017

All that happened in the PE/VC and M&A space in the week gone by

Private equity firm TA Associates invested about $25.5 million in drugmaker Shilpa Medicare in one of the top funding deals ......

Healthcare

30 May, 2016

Shilpa Medicare to acquire remaining stake in Nu Therapeutics

Pharmaceutical ingredients manufacturer Shilpa Medicare Ltd has received approval from its board to acquire the remaining stake in Hyderabad-based Nu ......